US investment bank makes appointments
This article was originally published in Scrip
The US investment bank Morgan Joseph & Co is to expand its coverage of the healthcare industry in the life sciences sector and has appointed senior investment banker Michael Innes and a senior equity research analyst Shiv Kapoor to cover the field. Both join from Ferris, Baker Watts.
You may also be interested in...
Lawyer asks US FDA to require another trial before licensing Mesoblast’s stem cell therapy for children with SR-aGVHD; Incyte’s Jakafi is only product approved for the indication.
Hanmi licenses out GLP-1/glucagon receptor dual agonist for NASH to Merck, in a deal worth up to $870m, marking a positive turn for the Korean firm's pipeline after Janssen returned rights last year.
Nomolotus discontinued social media claims that its herbal supplement supports users’ immune systems during the COVID-19 pandemic and customers reviews referencing the virus after the National Advertising Division questioned the statements as misleading.